A. G. Garro, R. Alasino, V. Leonhard, V. Heredia, D. Beltramo
{"title":"抗体可以自发地装载到含有肿瘤药物的单胞脂苷胶束上","authors":"A. G. Garro, R. Alasino, V. Leonhard, V. Heredia, D. Beltramo","doi":"10.35248/2157-7439.19.10.532","DOIUrl":null,"url":null,"abstract":"Recently, we demonstrated that GM1 micelles transport paclitaxel and doxorubicin with high efficiency. When this GM1-drugs complex is incubated with whole serum, albumin was the only one protein that binds spontaneously to form GM1-drug-albumin complex. Here, we show that, under specific physicochemical conditions, these micelles interact with antibodies forming GM1-IgG complexes. The load of IgG in GM1 reaches a maximum at ratios of 1/4 (w / w) incubating to 4.5 and preheating the micelles of GM1 at 55-60°C. The IgG of the GM1-IgG complex obtained under these experimental conditions retains the biological activity against the soluble and cellular antigens and is not displaced from the micelles in the presence of albumin, the main competitive binding protein. Treatment of GM1-IgG with pepsin, does not show the breakage of the IgG like control of free IgG, suggesting that IgG is deeply bound into GM1, probably via Fc. Moreover, the presence of 1 M NaCl does not prevent neither dissociate the complex, suggesting the hydrophobic nature of the interaction. The DLS and TEM results shows that GM1-IgG complexes have sizes significantly higher than those of GM1 micelles; this is directly related to the amount of IgG loaded. On the other hand GM1-IgG complex also retain the ability to encapsulate oncological drugs, but, an adequate sequence must be followed during the preparation, in order to obtain efficient GM1-drug-IgG ternary complexes. Moreover, the presence of IgG into GM1-oncological drugs complex do not affect the release or the cytotoxic activity of the encapsulated molecules such as Ptx or Doxo.","PeriodicalId":16532,"journal":{"name":"Journal of Nanomedicine & Nanotechnology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antibodies can be Spontaneously Loaded onto Monosialoganglioside Micelles Containing Oncological Drugs\",\"authors\":\"A. G. Garro, R. Alasino, V. Leonhard, V. Heredia, D. Beltramo\",\"doi\":\"10.35248/2157-7439.19.10.532\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Recently, we demonstrated that GM1 micelles transport paclitaxel and doxorubicin with high efficiency. When this GM1-drugs complex is incubated with whole serum, albumin was the only one protein that binds spontaneously to form GM1-drug-albumin complex. Here, we show that, under specific physicochemical conditions, these micelles interact with antibodies forming GM1-IgG complexes. The load of IgG in GM1 reaches a maximum at ratios of 1/4 (w / w) incubating to 4.5 and preheating the micelles of GM1 at 55-60°C. The IgG of the GM1-IgG complex obtained under these experimental conditions retains the biological activity against the soluble and cellular antigens and is not displaced from the micelles in the presence of albumin, the main competitive binding protein. Treatment of GM1-IgG with pepsin, does not show the breakage of the IgG like control of free IgG, suggesting that IgG is deeply bound into GM1, probably via Fc. Moreover, the presence of 1 M NaCl does not prevent neither dissociate the complex, suggesting the hydrophobic nature of the interaction. The DLS and TEM results shows that GM1-IgG complexes have sizes significantly higher than those of GM1 micelles; this is directly related to the amount of IgG loaded. On the other hand GM1-IgG complex also retain the ability to encapsulate oncological drugs, but, an adequate sequence must be followed during the preparation, in order to obtain efficient GM1-drug-IgG ternary complexes. Moreover, the presence of IgG into GM1-oncological drugs complex do not affect the release or the cytotoxic activity of the encapsulated molecules such as Ptx or Doxo.\",\"PeriodicalId\":16532,\"journal\":{\"name\":\"Journal of Nanomedicine & Nanotechnology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Nanomedicine & Nanotechnology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35248/2157-7439.19.10.532\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nanomedicine & Nanotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2157-7439.19.10.532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
最近,我们证明了GM1胶束可以高效地转运紫杉醇和阿霉素。当gm1 -药物复合物与全血清孵育时,白蛋白是唯一一种自发结合形成gm1 -药物-白蛋白复合物的蛋白质。在这里,我们表明,在特定的物理化学条件下,这些胶束与形成GM1-IgG复合物的抗体相互作用。在1/4 (w / w)的比例下,GM1中IgG的负载达到最大值,孵育至4.5,并在55-60℃预热GM1的胶束。在这些实验条件下获得的GM1-IgG复合物的IgG保留了对可溶性和细胞抗原的生物活性,并且在白蛋白(主要的竞争结合蛋白)存在时不会从胶束中移位。用胃蛋白酶处理GM1-IgG后,未见游离IgG的破坏,提示IgG可能通过Fc与GM1深度结合。此外,1 M NaCl的存在既不阻止也不解离复合物,表明相互作用的疏水性。DLS和TEM结果表明,GM1- igg复合物的大小明显大于GM1胶束;这与IgG的载量有直接关系。另一方面,GM1-IgG复合物也保留了包封肿瘤药物的能力,但在制备过程中必须遵循适当的序列,以获得有效的GM1-IgG -三元复合物。此外,IgG存在于gm1 -肿瘤药物复合物中,不影响包裹分子(如Ptx或Doxo)的释放或细胞毒性活性。
Antibodies can be Spontaneously Loaded onto Monosialoganglioside Micelles Containing Oncological Drugs
Recently, we demonstrated that GM1 micelles transport paclitaxel and doxorubicin with high efficiency. When this GM1-drugs complex is incubated with whole serum, albumin was the only one protein that binds spontaneously to form GM1-drug-albumin complex. Here, we show that, under specific physicochemical conditions, these micelles interact with antibodies forming GM1-IgG complexes. The load of IgG in GM1 reaches a maximum at ratios of 1/4 (w / w) incubating to 4.5 and preheating the micelles of GM1 at 55-60°C. The IgG of the GM1-IgG complex obtained under these experimental conditions retains the biological activity against the soluble and cellular antigens and is not displaced from the micelles in the presence of albumin, the main competitive binding protein. Treatment of GM1-IgG with pepsin, does not show the breakage of the IgG like control of free IgG, suggesting that IgG is deeply bound into GM1, probably via Fc. Moreover, the presence of 1 M NaCl does not prevent neither dissociate the complex, suggesting the hydrophobic nature of the interaction. The DLS and TEM results shows that GM1-IgG complexes have sizes significantly higher than those of GM1 micelles; this is directly related to the amount of IgG loaded. On the other hand GM1-IgG complex also retain the ability to encapsulate oncological drugs, but, an adequate sequence must be followed during the preparation, in order to obtain efficient GM1-drug-IgG ternary complexes. Moreover, the presence of IgG into GM1-oncological drugs complex do not affect the release or the cytotoxic activity of the encapsulated molecules such as Ptx or Doxo.